The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Feb / Biopharma's Big Transformation
Manufacture Bioprocessing Biopharma Facilities & Equipment Technology & Manufacturing Sponsored

Biopharma's Big Transformation

From digital technology to data analytics to continuous bioprocessing; the world of biopharma manufacturing is changing rapidly

02/27/2020 1 min read

Sponsored By

Cytiva

Share

In May 2019, Cytiva brought experts together at its Uppsala, Sweden, site for Bioprocess Days: an event to discuss the future of bioprocessing. Key themes involved digital technology, data and analytics, continuous processing, advanced medicine and more. This eBook includes insight from a range of speakers who attended the event, including Jun Huang from Pfizer, Wei Gong from Henlius Biotech, and Carol Knevelman from Oxford Biomedica. We also catch up with Cytiva’s Günter Jagschies.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

The Mindset for Success in Biopharma's New Multipolar World
Biopharma Development & Clinical Outsourcing
The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

10 min read

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

Biopharma Labs Have an Integration Debt Problem
Biopharma Technology & Manufacturing
Biopharma Labs Have an Integration Debt Problem

August 17, 2026

5 min read

Biopharma labs are investing heavily in digital tools, but without trusted data architecture, each new platform can add another point of failure

Musings from The Power List: Ali Pashazadeh
Outsourcing Biopharma Business & Trends
Musings from The Power List: Ali Pashazadeh

August 7, 2026

7 min read

Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier

Moving Glycosylation Control Upstream
Biopharma Interviews Technology & Manufacturing
Moving Glycosylation Control Upstream

August 6, 2026

7 min read

Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: